Moderna's Bird Flu Vaccine Gets CEPI Funding for Phase 3 Trial

Modernas stock surges as CEPI invests $54.3M in Phase Three trial for pandemic influenza vaccine, marking a significant step towards potential approval.The Daily News Now! — Every city. Every story. AI-powered. Hosted on Acast. See acast.com/privacy for more information.